ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by NBC Securities Inc.

NBC Securities Inc. cut its position in ARK Genomic Revolution ETF (BATS:ARKG) by 53.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,625 shares of the company’s stock after selling 1,900 shares during the quarter. NBC Securities Inc.’s holdings in ARK Genomic Revolution ETF were worth $46,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Operose Advisors LLC purchased a new position in ARK Genomic Revolution ETF during the 3rd quarter valued at about $25,000. Principal Securities Inc. purchased a new position in shares of ARK Genomic Revolution ETF in the fourth quarter valued at approximately $32,000. Northwest Financial Advisors acquired a new position in shares of ARK Genomic Revolution ETF in the fourth quarter valued at approximately $47,000. Tidemark LLC purchased a new stake in ARK Genomic Revolution ETF during the 4th quarter worth approximately $48,000. Finally, Naples Money Management LLC acquired a new stake in ARK Genomic Revolution ETF during the 4th quarter worth approximately $63,000.

ARK Genomic Revolution ETF Price Performance

BATS:ARKG opened at $24.62 on Tuesday. The stock has a 50 day simple moving average of $24.99 and a two-hundred day simple moving average of $28.22.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.